Christopher S Lynch's most recent trade in Corebridge Financial Inc. was a trade of 55,631 Common Stock done . Disclosure was reported to the exchange on June 21, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Corebridge Financial Inc. | Christopher S. Lynch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2024 | 55,631 | 23,402 | - | 0 | Common Stock | |
Corebridge Financial Inc. | Christopher S. Lynch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2024 | 5,631 | 23,402 | - | 0 | Common Stock | |
Tenet Healthcare Corp. | Christopher S. Lynch | Director | Sale of securities on an exchange or to another person at price $ 133.83 per share. | 30 May 2024 | 10,861 | 14,759 (0%) | 0% | 133.8 | 1,453,528 | Common Stock |
Tenet Healthcare Corp. | Christopher S. Lynch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 1,551 | 1,551 | - | - | Restricted Stock Units | |
Tenet Healthcare Corp. | S. Lynch Christopher | Director | Sale of securities on an exchange or to another person at price $ 89.60 per share. | 15 Feb 2024 | 7,978 | 25,620 (0%) | 0% | 89.6 | 714,829 | Common Stock |
Corebridge Financial Inc. | Christopher S. Lynch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2023 | 9,981 | 17,839 | - | 0 | Common Stock | |
Tenet Healthcare Corp. | Christopher S. Lynch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2023 | 3,682 | 33,598 (0%) | 0% | 0 | Common Stock | |
Corebridge Financial Inc. | Christopher S. Lynch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2022 | 7,858 | 7,858 | - | 0 | Common Stock | |
Tenet Healthcare Corp. | Christopher S. Lynch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2022 | 3,836 | 29,916 (0%) | 0% | 0 | Common Stock | |
American International Gro... | Christopher S. Lynch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2022 | 170 | 35,970 | - | - | Deferred Stock Unit | |
American International Gro... | Christopher S. Lynch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 194 | 35,800 | - | - | Deferred Stock Unit | |
American International Gro... | Christopher S. Lynch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2021 | 182 | 35,606 | - | - | Deferred Stock Unit | |
American International Gro... | Christopher S. Lynch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2021 | 232 | 35,424 | - | - | Deferred Stock Unit | |
American International Gro... | Christopher S. Lynch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2021 | 3,694 | 35,192 | - | - | Deferred Stock Unit | |
Tenet Healthcare Corp. | Christopher S. Lynch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2021 | 3,960 | 26,080 (0%) | 0% | 0 | Common Stock | |
American International Gro... | Christopher S. Lynch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2021 | 215 | 31,498 | - | - | Deferred Stock Unit | |
American International Gro... | Christopher S. Lynch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 267 | 31,283 | - | - | Deferred Stock Unit | |
American International Gro... | Christopher S. Lynch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2020 | 353 | 31,016 | - | - | Deferred Stock Unit | |
American International Gro... | Christopher S. Lynch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2020 | 327 | 30,663 | - | - | Deferred Stock Unit | |
Tenet Healthcare Corp. | Christopher S. Lynch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2020 | 11,139 | 22,120 (0%) | 0% | 0 | Common Stock |